This website uses cookies so that we can offer you the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.
BRUCELLOSIS
An essential and innovative tool in the control of ovine and caprine brucellosis.
THE VACCINE OF CHOICE
Manufactured in compliance with OIE and EU standards, OCUREV was the first REV-1 conjunctival vaccine developed and made available. Now, it is an essential tool in the control of ovine and caprine Brucellosis in numerous countries worldwide.
FIRST STEP IN THE CONTROL OF BRUCELLA MELITENSIS
Caprine and ovine Brucellosis is a major cause of abortion, resulting in significant economic losses for farmers. Vaccination is a practical and effective method to reduce the incidence of brucellosis in endemic areas.
EASY ADMINISTRATION BY OCULAR ROUTE
The Patent Blue V allows the differentiation of vaccinated animals from not-vaccinated
PERFECT DOSE PRECISION
OCUREV combines perfect dissolution of the freeze-dried cake and high dosage precision of the dropper, allowing optimal and efficient application by ocular route.
LONG-LASTING PROTECTION
OCUREV offers long-lasting protection due to cell-mediated immune response, which is the principal defense mechanism against Brucella disease.
Helping to decrease human BRUCELLOSIS
Brucellosis is highly pathogenic for humans, causing one of the most serious zoonoses in the world. Animal vaccination has been shown to reduce the zoonotic spread of the disease, leading to a notable decrease in the prevalence of human Brucellosis.
AVOIDING INTERFERENCE WITH SEROLOGICAL TESTS
When OCUREV is administered by ocular route in sheep and goats aged 3 to 6 months, it induces a short-lasting serological response that avoids interference with conventional serological tests. OCUREV is compatible with eradication programs based on mass vaccination and test-and-slaughter principles.
SUPPRESSION OF THE INFECTION PRESSURE
Vaccination results in elimination of the clinical signs (abortions) and the excretion of bacteria Brucella melitensis bacteria, thus reducing contamination of the environment and disease transmission.
STABILITY
OCUREV is extremely stable and shows no tendency to revert virulence. OCUREV has a shelf life of 24 months, allowing prolonged storage with the same quality of protection. Investigations carried out on OCUREV indicate that it is thermostable. It can be transported and kept at a maximum of 37°C for a period of time not exceeding 7 days, facilitating transport for application in herds with difficult access.